Adrenal Insufficiency with Anticancer Tyrosine Kinase Inhibitors Targeting Vascular Endothelial Growth Factor Receptor: Analysis of the FDA Adverse Event Reporting System

SIMPLE SUMMARY: This real-world post-marketing research described clinical features of adrenal insufficiency with anticancer drugs targeting vascular endothelial growth factor receptor reported to the Food and Drug Administration pharmacovigilance database. A robust signal emerged for multi-targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Raschi, Emanuel, Fusaroli, Michele, Giunchi, Valentina, Repaci, Andrea, Pelusi, Carla, Mollica, Veronica, Massari, Francesco, Ardizzoni, Andrea, Poluzzi, Elisabetta, Pagotto, Uberto, Di Dalmazi, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559636/
https://www.ncbi.nlm.nih.gov/pubmed/36230533
http://dx.doi.org/10.3390/cancers14194610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559636/
https://www.ncbi.nlm.nih.gov/pubmed/36230533
http://dx.doi.org/10.3390/cancers14194610

Ejemplares similares